Century Therapeutics Inc
IPSC
Get informed when a big investor buys or sells
+ FollowMarket Cap$212.1M
Close$
$-0.25
112.1% downside
Current Fair Value
112.1% downsideOvervalued by 112.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $212.10 Million |
|---|---|
| Enterprise Value | $204.99 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.11 |
| Beta | 1.56 |
| Outstanding Shares | 86,556,515 |
Return
| Return on Equity | -40.71% |
|---|---|
| Return on Assets | -33.01% |
| Return on Invested Capital | -38.36% |
Valuation & Multiples
| P/E Ratio | -1.97 |
|---|---|
| PEG | 1.53 |
| Price to Sales | - |
| Price to Book Ratio | 0.69 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.71 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.15
Average shareholder expectationRevenue Estimate
$2.87 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$2.17 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 41,500▲ Infinity% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 158.68%▲ 128.95% |
|---|---|
| Total Invested | $309.30M▲ 1109.62% |
| Investors Holding | 73▲ 27.00% |
ESG Score
No data
About Century Therapeutics Inc
102 employees